Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate

G. Genovese, R. Caorsi, C. Moltrasio, A. V. Marzano

Research output: Contribution to journalArticlepeer-review

Abstract

SAPHO syndrome, namely Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis, is a rare autoinflammatory chronic disease presenting with non-infectious inflammatory osteitis, sterile joint inflammation and skin manifestations, including palmoplantar pustulosis and severe acne. The case of a 15-year-old boy affected by SAPHO syndrome and hidradenitis suppurativa (HS) is presented and discussed. Coexistence of these two diseases may represent a therapeutic challenge and this case confirms literature data reporting the efficacy of the combination of methotrexate and adalimumab in SAPHO complicated by HS.

Original languageEnglish
Pages (from-to)40-41
Number of pages2
JournalJournal of the European Academy of Dermatology and Venereology : JEADV
Volume33
DOIs
Publication statusPublished - Oct 1 2019

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate'. Together they form a unique fingerprint.

Cite this